tetraisopropylpyrophosphamide has been researched along with Glioma in 1 studies
Tetraisopropylpyrophosphamide: N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Razon, N | 1 |
Soreq, H | 1 |
Roth, E | 1 |
Bartal, A | 1 |
Silman, I | 1 |
1 other study available for tetraisopropylpyrophosphamide and Glioma
Article | Year |
---|---|
Characterization of activities and forms of cholinesterases in human primary brain tumors.
Topics: Acetylcholinesterase; Adolescent; Adult; Aged; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-di | 1984 |